Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00336076 · ClinicalTrials.gov registry record

Molecular Mechanisms and Diagnosis of Mastocytosis

A clinical trial, sponsored by University of Michigan.

Completed
Registry status
136
Enrollment target

NCT00336076 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 136 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00336076 has completed, sponsored by University of Michigan.

COMPLETED
Registry status
136 participants
Enrollment target

Study Summary

Mastocytosis is a disorder characterized by presence of excessive numbers of mast cells in skin, bone marrow and internal organs. It can affect both children and adults, males and females and individuals from all ethnic backgrounds, although precise demographic information about the affected populations is not available as it is a rare disorder. Mastocytosis in children is generally limited to the skin and follows a self limited course, while it is a disorder of the hematopoietic stem cell associated with somatic mutations of the c-kit gene in most patients with adult-onset of disease. There is no known curative therapy for most patients with systemic mastocytosis. Recent research studies identified several subtypes of disease with distinct clinical and pathologic features, however, a precise understanding of the incidence as well as molecular pathology of different disease subtypes is lacking. This study aims to examine molecular and cellular pathological aspects of disease in patients with mastocytosis and correlate findings with clinical presentation and prognosis. Patients will undergo a routine history and physical examination, and diagnostic tests will be ordered as dictated by each patient's clinical presentation. Blood and bone marrow will be obtained for diagnostic and research purposes. Genetic analysis of the c-kit gene regulating mast cell growth and differentiation will be performed. It is hoped that findings obtained from this study will help to design novel therapies for mastocytosis and other disorders in which mast cells play a critical role.

Interventions

  • OTHER Collection of blood and bone marrow

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2004-07
Est. Completion 2009-07

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT00336076

The ClinicalTrials.gov registry entry for NCT00336076 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Collection of blood and bone marrow is the first listed.

NCT00336076 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00336076 about?

NCT00336076 is a clinical study titled "Molecular Mechanisms and Diagnosis of Mastocytosis". Mastocytosis is a disorder characterized by presence of excessive numbers of mast cells in skin, bone marrow and internal organs. It can affect both children and adults, males and females and individuals from all ethnic backgrounds, although precise demographic information about the affected populat...

What is the current status of trial NCT00336076?

This trial is currently completed. The enrollment target is 136 participants. The study started on 2004-07. Estimated completion is 2009-07.

What interventions are being tested in trial NCT00336076?

The interventions under investigation include: Collection of blood and bone marrow (OTHER).

Who is sponsoring clinical trial NCT00336076?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.